These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7220515)

  • 1. [Immunological status change in leukemia patients with infectious complications and during immunotherapy].
    Rozanova LM; Smirnova AI; Shcherbakova EG; Zinkovskaia LN; Eremina TN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):18-20. PubMed ID: 7220515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some aspects of the disturbances of humoral and cellular immunological barrier in leukemia patients].
    Szmigiel Z
    Przegl Lek; 1973; 30(6):514-7. PubMed ID: 4581660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific immunity regulation in acute leukemia and its therapeutic potentials].
    Bergol'ts VM; Kisliak NS; Eremeev VS; Rumiantsev AG; Akimova GV
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):21-5. PubMed ID: 6946411
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disorders of humoral and cellular immunity in acute adult leukemia].
    Steruská M; Sakalová A; Gazová S; Drobná V; Chabronová I; Hrubisko M
    Vnitr Lek; 1979 Jan; 25(1):29-33. PubMed ID: 283625
    [No Abstract]   [Full Text] [Related]  

  • 5. [Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy].
    Esposito L; Benedetto N; Guerriero A
    Pediatria (Napoli); 1980 Dec; 88(4):521-31. PubMed ID: 6974847
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity in the acute leukaemias.
    Lancet; 1973 Feb; 1(7799):355-6. PubMed ID: 4121941
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antileukemic cellular immunity characteristics in the immunotherapy of acute lympholeukemia in children].
    Bergol'ts VM; Osipov SG; Eremeev VS; Rumiantseva AG; Akimova GV
    Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):12-4. PubMed ID: 6948291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blast-cell bank designated for carrying out immunological studies and immunotherapy of leukemia].
    Bulycheva TI; Leontovich VA; Abezgauz NN; Vonograd-Finkel' FR; Agranenko VA
    Probl Gematol Pereliv Krovi; 1977 Feb; (2):32-5. PubMed ID: 877027
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the immune status in chronic lymphatic leukemia as dependent on the clinical stage].
    Costescu M; Moţoiu I; Dumitrescu A; Funduc I; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):439-44. PubMed ID: 6143363
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of human leukemia with neuraminidase-modified cells.
    Holland JF; Bekesi JG
    Med Clin North Am; 1976 May; 60(3):539-49. PubMed ID: 1063908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of monitoring the cellular and humoral immunity in patients with chronic lymphocytic leukemia].
    Matĕja F; Fixa B; Radochová D; Mazák J; Vanásek J; Chrobák L; Komárková O
    Vnitr Lek; 1974 Jul; 20(6):590-5. PubMed ID: 4844793
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interaction of cellular and humoral immunity factors in acute leukemia].
    Akimova GV; Osipov SG; Eremeev VS; Rumiantsev AG; Bergol'ts VM
    Vopr Onkol; 1982; 28(2):84-8. PubMed ID: 6950589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological evaluation of FAB classification of acute leukemia].
    Takiguchi T; Konda S
    Rinsho Ketsueki; 1982 Jul; 23(7):1030-6. PubMed ID: 6958887
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity in malignant disease.
    Fairley GH
    Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
    [No Abstract]   [Full Text] [Related]  

  • 15. Active immunization of children suffering from acute leukemia in remission with "living" mixed leukoblast vaccine and means of enhancement of antileukemic immunity.
    Skurkovich SV; Kisljak NS; Bulicheva TI; Makhonova LA; Majakova SA; Skorikova AS; Erjemkina EI
    Ann N Y Acad Sci; 1976; 277(00):384-95. PubMed ID: 1069557
    [No Abstract]   [Full Text] [Related]  

  • 16. [Active immunotherapy with allogenic leukemic cells in complex treatment of patients with acute leukemia].
    Riabova TI; Riabov NV; Gritsenko TV; Svedentsov EP
    Sov Med; 1978 Aug; (8):32-6. PubMed ID: 705452
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunotherapy of acute leukemia].
    Skurkovich SV; Bulycheva TI
    Sov Med; 1978 Aug; (8):26-31. PubMed ID: 705451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pro and con: Immunotherapy in acute leukemia. Arguments for immunotherapy].
    Büchner T; Urbanitz D
    Internist (Berl); 1980 Jul; 21(7):362-6. PubMed ID: 7007269
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic aspects of leukemia.
    Johnson AM
    N C Med J; 1973 Sep; 34(9):698-701. PubMed ID: 4518116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pro and con: Immunotherapy in acute leukemia. Arguments against immunotherapy].
    Hirschmann WD
    Internist (Berl); 1980 Jul; 21(7):367-70. PubMed ID: 7007270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.